-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
U.
ATTR is caused by the accumulation of transthyretin in important tissues due to mutation or aging, so it is divided into two subtypes: hereditary and senile, mainly affecting the heart (ATTR-CM) and nerve tissue (FAP)
High doses of NTLA-2001 appear to be more effective at lowering TTR levels than existing therapies, but this biomarker therapy needs to be translated into disease treatments that actually improve patients' quality of life
Although one injection of Yongyi is a theoretical advantage, it is more difficult to reverse if rare toxic side effects occur.
Coincidentally, the historical issue of patents resurfaced at the height of the technology's brilliance, as the patent lawsuit was destined to bring down the final round because of the importance of the technology